APA (7th ed.) Citation

JM, S., & RS, F. (2021). Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. The Journal of rheumatology, 48(11), 1718. https://doi.org/10.3899/jrheum.210361

Chicago Style (17th ed.) Citation

JM, Springer, and Funk RS. "Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis." The Journal of Rheumatology 48, no. 11 (2021): 1718. https://doi.org/10.3899/jrheum.210361.

MLA (9th ed.) Citation

JM, Springer, and Funk RS. "Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis." The Journal of Rheumatology, vol. 48, no. 11, 2021, p. 1718, https://doi.org/10.3899/jrheum.210361.